Brooke Hayward - Publications, H-index & Citations

Brooke Hayward

EMD Serono Inc.

16H指数

120论文数

2.8K被引数

收录论文 17

发表时间

Revisiting HIV-Associated Wasting: Results from a US Cross-Sectional Survey of Health Care Providers' Knowledge, Attitude, and Current Practices 重新审视HIV相关消瘦：来自美国医疗保健提供者知识、态度和当前实践横断面调查的结果

AIDS Research and Human Retroviruses

IF1.1

2026-05-01

PREAI

Lee, Daniel; Brawley, Scott; Hayward, Brooke; Mari, Elisabeth; Harbour, Michael; Felizzola, Jesus

An Agile Approach to Collaborative Online International Learning: A Case Study of Virtual Indigenous Food Sovereignty and Public Policy Internships in Aotearoa (New Zealand) and Ontario, Canada 一种敏捷方法用于协作式在线国际学习：一项关于奥塔哥（新西兰）和安大略省（加拿大）虚拟原住民食品主权与公共政策实习的案例研究

ONLINE LEARNING

IF2.3

2024-12-01

OAAI

Fadgen, Tim; Porter, Tony; Edge, Kiri; Gabel, Chelsea; Hayward, Brooke; Xavier, Adrianne Lickers

Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35-40 years

REPRODUCTIVE BIOMEDICINE ONLINE

IF3.5

2024-06-01

OAAI

Bielfeld, Alexandra P.; Schwarze, Juan-Enrique; Verpillat, Patrice; Lispi, Monica; Fischer, Robert; Hayward, Brooke; Chuderland, Dana; D'Hooghe, Thomas; Krussel, Jan-Steffan

Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-09-01

OAAI

Martini, Anne E.; Beall, Stephanie; Ball, G. David; Hayward, Brooke; D'Hooghe, Thomas; Mahony, Mary C.; Collares, Fabricio; Catherino, Allison B.

Effectiveness of recombinant human follicle- stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35e40 years: A German database study (Withdrawn Publication. See vol. 89, 2023)

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

IF4.1

2023-07-01

OAAI

Bielfeld, A. P.; Schwarze, J. E.; Verpillat, P.; Lispi, M.; Fischer, R.; Hayward, B.; Chuderland, D.; D'Hooghe, T.; Krussel, J. S.

Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35-40 years: A German database study (Withdrawal of Vol 89, art no 102350, 2023)

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

IF4.1

2023-07-01

OAAI

Bielfeld, A. P.; Schwarze, J. E.; Verpillat, P.; Lispi, M.; Fischer, R.; Hayward, B.; Chuderland, D.; D'Hooghe, T.; Krussel, J. S.

Recombinant Human Follicle-Stimulating Hormone Alfa Dose Adjustment in US Clinical Practice: An Observational, Retrospective Analysis of a Real-World Electronic Medical Records Database 美国临床实践中重组人促卵泡激素α的剂量调整：基于真实世界电子病历数据库的观察性回顾性分析

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2021-12-09

OAAI

Mahony, Mary C.; Hayward, Brooke; Mottla, Gilbert L.; Richter, Kevin S.; Beall, Stephanie; Ball, G. David; D'Hooghe, Thomas

Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2021-06-09

OAAI

Mahende, Muhidin K.; Huber, Eric; Kourany-Lefoll, Elly; Ali, Ali; Hayward, Brooke; Bezuidenhout, Deon; Bagchus, Wilhelmina; Kabanywanyi, Abdunoor M.

Subcutaneous Interferon-1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance

ADVANCES IN THERAPY

IF4

2018-09-25

OAAI

Sabido, Meritxell; Venkatesh, Saritha; Hayward, Brooke; Aldridge, Julie; Gillett, Alan

Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study

EXPERT OPINION ON DRUG DELIVERY

IF5.4

2017-12-05

OAAI

Wray, Sibyl; Hayward, Brooke; Dangond, Fernando; Singer, Barry

The Human Oocyte Preservation Experience (HOPE) Registry: evaluation of cryopreservation techniques and oocyte source on outcomes

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY

IF4.7

2017-02-07

OAAI

Nagy, Zsolt Peter; Anderson, Robert E.; Feinberg, Eve C.; Hayward, Brooke; Mahony, Mary C.

METHODOLOGY USING PHARMACY AND MEDICAL CLAIMS DATA TO EVALUATE REAL-WORLD OUTCOMES AND COSTS OF IVF TREATMENT IN THE US

VALUE IN HEALTH

IF6

2015-05-01

OAAI

Corvino, F. A.; Surinach, A.; Locklear, J. C.; Howe, A. M.; Hayward, B.; Mahony, M. C.

Human factors engineering and design validation for the redesigned follitropin alfa pen injection device

EXPERT OPINION ON DRUG DELIVERY

IF5.4

2015-04-21

OAAI

Mahony, Mary C.; Patterson, Patricia; Hayward, Brooke; North, Robert; Green, Dawne

Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study

EXPERT OPINION ON DRUG DELIVERY

IF5.4

2011-10-27

PREAI

Wray, Sibyl; Armstrong, Robert; Herrman, Craig; Calkwood, Jonathan; Cascione, Mark; Watsky, Eric; Hayward, Brooke; Mercer, Brian; Dangond, Fernando

Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII

HAEMOPHILIA

IF3

2009-06-24

PREAI

Recht, M.; Nemes, L.; Matysiak, M.; Manco-Johnson, M.; Lusher, J.; Smith, M.; Mannucci, P.; Hay, C.; Abshire, T.; O'Brien, A.; Hayward, B.; Udata, C.; Roth, D. A.; Arkin, S.

Xyntha® is effective and safe in previously treated patients with severe haemophilia A: Final results of a pivotal phase III study

HAEMOPHILIA

IF3

2009-03-23

PREAI

Evans, Katia; Janco, Robert; Udata, Chandrasekhar; Brien, Amanda O.; Hayward, Brooke; Arkin, Steven

A novel TNFRSF1A splice mutation associated with increased nuclear factor κappaB (NF-κB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)与肿瘤坏死因子受体相关的周期性综合症 (TRAPS) 患者的核因子 κ appab (nf-κb) 转录因子活化增加相关的新型TNFRSF1A剪接突变

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2008-11-01

PREAI

Churchman, S. M.; Church, L. D.; Savic, S.; Coulthard, L. R.; Hayward, B.; Nedjai, B.; Turner, M. D.; Mathews, R. J.; Baguley, E.; Hitman, G. A.; Gooi, H. C.; Wood, P. M. D.; Emery, P.; McDermott, M. F.

研究方向